@petrajana.bsky.social
Medical Director Professional Practice, CO Faculty, Royal College of Radiologists; Consultant Clinical Oncologist Head & Neck and Lung Cancer, Somerset Foundation Trust. She/her. Views expressed are my own.
@prof-ali-g.bsky.social
Professor of Precision Oncology at Newcastle and Clinical Director NE England Genomic Medicine Service. Interests include drug development especially in thoracic malignancy; biomarkers including cfDNA and treatment of older patients with cancer
@oncogenecancer.bsky.social
🔬 Advancing Research. Empowering Patients. Championing Advocacy. We’re patients & families dedicated to improving outcomes for people with oncogene-driven lung cancer through education, support, and powering cutting-edge research.
@jameslindalliance.bsky.social
Bringing patients, carers, and health and care professionals together to identify and prioritise the unanswered questions they want health research to address. Visit our website: https://www.jla.nihr.ac.uk/
@theguardian.com
The need for independent journalism has never been greater. Become a Guardian supporter https://support.theguardian.com 🇺🇸 Guardian US https://bsky.app/profile/us.theguardian.com 🇦🇺 Guardian Australia https://bsky.app/profile/australia.theguardian.com
@predict-meso.bsky.social
PREDICT-Meso:PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma. Worldwide Network aiming to transform Mesothelioma diagnosis&treatment
@mesouk.bsky.social
Mesothelioma UK is a national resource centre dedicated to providing specialist Mesothelioma information, support & improved care and treatment. https://www.mesothelioma.uk.com/
@bristolaru.bsky.social
Designing, leading and delivering high quality, patient-centred respiratory research. http://www.bristol.ac.uk/translational-health-sciences/research/respiratory/
@glennmasson.bsky.social
Scientist at School of Medicine, University of Dundee. Using cryo-EM and my beloved HDX-MS to investigate all things ISR Kinase - GCN2, HRI, PERK (and I guess PKR). https://glennmasson.com
@davidfairen.bsky.social
Molecular Engineering at Cambridge. Materials discovery, monolithic metal-organic frameworks (MOFs), energy transition, drug delivery, RNA, and more. Linking academia and industry. Founder of Immaterial and Vector Bioscience
@mgarnett.bsky.social
Cancer programme Faculty @sangerinstitute.bsky.social & founder MosaicTx developing precision combination therapies. #Cancer, Functional genomics, biomarkers, target discovery, #organoid, #CRISPR. Proud 🇨🇦.
@joshsearle.bsky.social
Cancer cell biologist; pleural mesothelioma and lung cancer; postdoc in Janes lab @ UCL Respiratory Medicine; PhD in Malliri lab @ UoM
@donnawakefield.bsky.social
Palliative Medicine Consultant 🩺 in North East England, NIHR Doctoral Fellow, PhD on #Inequalities in lung disease, #Mesothelioma #LungCancer #COPD #ILD🫁 🏳️🌈 #LGBTQ 💪🏻 #WomenInMedicine Book/coffee/travel/photography enthusiast ☕️📚📷 🌊⛰️
@kevingblyth.bsky.social
Professor of Respiratory Medicine @ University of Glasgow | Respiratory Consultant QEUH | Mesothelioma | Pleural | Lung | Cancer Evolution | Trustee Mesothelioma UK https://www.predictmeso.com https://pubmed.ncbi.nlm.nih.gov/?term=blyth+kg&sort=date
@profmarciniak.bsky.social
Professor of Respiratory Science University of Cambridge. Lung doctor. Fellow St Catharine’s College. Cell biology. Pleural medicine. Rare disease. Genetics. Lab webpage = https://www.cimr.cam.ac.uk/staff/professor-stefan-marciniak
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]